Abstract
Purpose
To investigate the association between maternal HBsAg-positive status and pregnancy outcomes.
Methods
The study enrolled women with singleton pregnancies who delivered during January–December 2018. Data of maternal demographics and main adverse pregnancy outcomes were collected from the institutional medical records and analyzed by univariate and multivariate logistic regression models to determine the association between maternal HBV markers (HBsAg/HBeAg/HBV-DNA loads status) and adverse pregnancy outcomes.
Results
Total 1146 HBsAg-positive and 18,354 HBsAg-negative pregnant women were included. After adjusting for potential confounding variables, maternal HBsAg-positive status was associated with a high risk of gestational diabetes mellitus (GDM) [adjusted odds ratio (aOR) = 1.24; 95% confidence interval (CI) 1.07–1.43], intrahepatic cholestasis of pregnancy (ICP) (aOR = 3.83; 95% CI 3.14–4.68), preterm birth (aOR = 1.42; 95% CI 1.17–1.72), and neonatal asphyxia (aOR = 2.20; 95% CI 1.34–3.63). Further, higher risks of ICP and neonatal asphyxia remained with either HBeAg-positive status (aOR = 1.64; 95% CI 1.10–2.44; aOR = 3.08; 95% CI 1.17–8.00) or high HBV-DNA load during the second trimester (aOR = 1.52; 95% CI 1.06–2.35; aOR = 4.20; 95% CI 4.20–15.83) among HBsAg-positive pregnant women.
Conclusion
Women with maternal HBsAg-positive status may have increased risks of GDM, ICP, preterm birth, and neonatal asphyxia; furthermore, the risks of ICP and neonatal asphyxia were higher in women with HBeAg-positive status and a high HBV-DNA load during the second trimester among the HBsAg-positive pregnant women, implying that careful surveillance for chronic HBV infection during pregnancy is warranted.
Similar content being viewed by others
References
Listed NA (2017) New hepatitis data highlight need for urgent global response. Saudi Med J 38(6):672–675
Ott JJ, Stevens GA, Groeger J, Wiersma ST (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30(12):2212–2219. https://doi.org/10.1016/j.vaccine.2011.12.116
Borchardt SM, Kocharian A, Hopfensperger D, Davis JP (2016) Prevention of perinatal transmission of hepatitis B virus: assessment among wisconsin maternity hospitals. WMJ 115(2):74–79
Xiao B, Liu A, Zhang M, Xue H, Zhu Y (2019) Observation of the effect of the pregnancy complicated with the hepatitis B infection on the lying-in women and neonates. Saudi J Biol Sci 26(8):1978–1981
Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y (2009) Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine 27(47):6550–6557. https://doi.org/10.1016/j.vaccine.2009.08.048
Tse KY, Ho LF, Lao T (2005) The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol 43(5):771–775. https://doi.org/10.1016/j.jhep.2005.05.023
Reddick KL, Jhaveri R, Gandhi M, James AH, Swamy GK (2011) Pregnancy outcomes associated with viral hepatitis. J Viral Hepatitis 18(7):e394–398. https://doi.org/10.1111/j.1365-2893.2011.01436.x
Lao TT, Chan BC, Leung WC, Ho LF, Tse KY (2007) Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol 47(1):46–50. https://doi.org/10.1016/j.jhep.2007.02.014
Safir A, Levy A, Sikuler E, Sheiner E (2010) Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Int 30(5):765–770. https://doi.org/10.1111/j.1478-3231.2010.02218.x
Abu Freha N, Wainstock T, Poupko L, Yonat Shemer A, Sergienko R, Sheiner E (2020) Maternal hepatitis B or hepatitis C virus carrier status and long-term infectious morbidity of the offspring: a population-based cohort study. J Viral Hepatitis. https://doi.org/10.1111/jvh.13300
A N, W T, M TN, S E (2020) Maternal hepatitis B virus or hepatitis C virus carrier status and long-term endocrine morbidity of the offspring-a population-based cohort study. J Clin Med. https://doi.org/10.3390/jcm9030796
Y G-Y, T W, N A-F, E S (2019) Maternal hepatitis B virus and hepatitis C virus carrier status during pregnancy and long-term respiratory complications in the offspring. Early Hum Dev 140:104904. https://doi.org/10.1016/j.earlhumdev.2019.104904
I Y, E S, N A-F, T W (2019) Maternal hepatitis B or C status and the long-term risk of gastrointestinal morbidity for offspring: a population-based cohort study. Liver Int 39(11):2046–2051. https://doi.org/10.1111/liv.14193
Fan L, Owusu-Edusei K Jr, Schillie SF, Murphy TV (2016) Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection. Hepatology (Baltimore, MD) 63(5):1471–1480. https://doi.org/10.1002/hep.28310
Xu YY, Liu HH, Zhong YW, Liu C, Wang Y, Jia LL, Qiao F, Li XX, Zhang CF, Li SL, Li P, Song HB, Li Q (2015) Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus. Int J Biol Sci 11(3):266–273. https://doi.org/10.7150/ijbs.10813
Wan Z, Zhou A, Zhu H, Lin X, Hu D, Peng S, Zhang B, Du Y (2018) Maternal Hepatitis B virus infection and pregnancy outcomes. J Clin Gastroenterol 52(1):73–78
To WW, Cheung W, Mok KM (2003) Hepatitis B surface antigen carrier status and its correlation to maternal hypertension. Aust N Z J Obstet Gynaecol 43(2):119–122
Stokkeland K, Ludvigsson JF, Hultcrantz R, Ekbom A, Höijer J, Bottai M, Stephansson O (2017) Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in Sweden. Eur J Epidemiol 32(7):617–625
Cui A-M, Shao J-G, Li H-B, Shen Y, Chen Z-X, Zhang S, Bian Z-L, Qin G, Cheng X-Y (2017) Association of chronic hepatitis B virus infection with preterm birth: our experience and meta-analysis. J Perinat Med 45(8):933–940
Kong D, Liu H, Wei S, Wang Y, Hu A, Han W, Zhao N, Lu Y, Zheng Y (2014) A meta-analysis of the association between gestational diabetes mellitus and chronic hepatitis B infection during pregnancy. BMC Res Notes 7:139. https://doi.org/10.1186/1756-0500-7-139
Peng S, Wan Z, Lin X, Li X, Du Y (2019) Maternal hepatitis B surface antigen carrier status increased the incidence of gestational diabetes mellitus. BMC Infect Dis 19(1):147. https://doi.org/10.1186/s12879-019-3749-1
Tan J, Liu X, Mao X, Yu J, Chen M, Li Y, Sun X (2016) HBsAg positivity during pregnancy and adverse maternal outcomes: a retrospective cohort analysis. J Viral Hepatitis 23(10):812–819. https://doi.org/10.1111/jvh.12545
Huang X, Tan H, Li X, Zhou S, Wen SW, Luo M (2014) Maternal chronic HBV infection would not increase the risk of pregnancy-induced hypertension–results from pregnancy cohort in Liuyang rural China. PLoS ONE 9(12):e114248. https://doi.org/10.1371/journal.pone.0114248
Cai Q, Liu H, Han W, Liu L, Xu Y, He Y, Li Q, Zhang M, Hu A, Zheng Y (2019) Maternal HBsAg carriers and adverse pregnancy outcomes: A hospital-based prospective cohort analysis. J Viral Hepatitis 26(8):1011–1018. https://doi.org/10.1111/jvh.13105
Lumley J (2003) Defining the problem: the epidemiology of preterm birth. BJOG 110(Suppl 20):3–7
Cui AM, Cheng XY, Shao JG, Li HB, Wang XL, Shen Y, Mao LJ, Zhang S, Liu HY, Zhang L, Qin G (2016) Maternal hepatitis B virus carrier status and pregnancy outcomes: a prospective cohort study. BMC Pregnancy Childbirth 16:87. https://doi.org/10.1186/s12884-016-0884-1
Smith DD, Rood KM (2020) Intrahepatic cholestasis of pregnancy. Clin Obstet Gynecol 63(1):134–151
Rook M, Vargas J, Caughey A, Bacchetti P, Rosenthal P, Bull L (2012) Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort. PLoS ONE 7(3):e28343. https://doi.org/10.1371/journal.pone.0028343
Medina Lomelí JM, Jáuregui Meléndrez RA, Medina Castro N, Medina Castro D (2012) Intrahepatic cholestasis of pregnancy: review. Ginecol Obstet Mex 80(4):285–294
Larson SP, Kovilam O, Agrawal DK (2016) Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy. Exp Rev Clin Immunol 12(1):39–48. https://doi.org/10.1586/1744666x.2016.1101344
Luo L, Wu J, Qu Y, Li J, Pan L, Li D, Wang H, Mu D (2015) Association between maternal HBsAg carrier status and neonatal adverse outcomes: meta-analysis. J Mater-Fetal Neonatal Med 28(11):1308–1317. https://doi.org/10.3109/14767058.2014.953475
Wong S, Chan LY, Yu V, Ho L (1999) Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 16(9):485–488. https://doi.org/10.1055/s-1999-6802
Bai H, Zhang L, Ma L, Dou XG, Feng GH, Zhao GZ (2007) Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism. World J Gastroenterol 13(26):3625–3630. https://doi.org/10.3748/wjg.v13.i26.3625
Janičko M, Veselíny E, Leško D, Jarčuška P (2013) Serum cholesterol is a significant and independent mortality predictor in liver cirrhosis patients. Ann Hepatol 12(4):581–587
Hu Y, Ding YL, Yu L (2014) The impact of intrahepatic cholestasis of pregnancy with hepatitis B virus infection on perinatal outcomes. Ther Clin Risk Manag 10:381–385. https://doi.org/10.2147/tcrm.s61530
Wood AM, Livingston EG, Hughes BL, Kuller JA (2018) Intrahepatic cholestasis of pregnancy: a review of diagnosis and management. Obstet Gynecol Surv 73(2):103–109. https://doi.org/10.1097/ogx.0000000000000524
Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51(7):2207–2213. https://doi.org/10.2337/diabetes.51.7.2207
Sheron N, Lau J, Daniels H, Goka J, Eddleston A, Alexander GJ, Williams R (1991) Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol 12(2):241–245. https://doi.org/10.1016/0168-8278(91)90945-8
Fernández-Real JM, Ricart-Engel W, Arroyo E, Balançá R, Casamitjana-Abella R, Cabrero D, Fernández-Castañer M, Soler J (1998) Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 21(1):62–68. https://doi.org/10.2337/diacare.21.1.62
Gomes CP, Torloni MR, Gueuvoghlanian-Silva BY, Alexandre SM, Mattar R, Daher S (2013) Cytokine levels in gestational diabetes mellitus: a systematic review of the literature. Am J Reprod Immunol 69(6):545–557. https://doi.org/10.1111/aji.12088
Lao TT, Sahota DS, Suen SS, Law LW, Leung TY (2012) Maternal HBsAg status and infant size—a Faustian bargain? J Viral Hepatitis 19(7):519–524. https://doi.org/10.1111/j.1365-2893.2011.01575.x
Hedderson M, Ehrlich S, Sridhar S, Darbinian J, Moore S, Ferrara A (2012) Racial/ethnic disparities in the prevalence of gestational diabetes mellitus by BMI. Diabetes Care 35(7):1492–1498. https://doi.org/10.2337/dc11-2267
Strong C, Lee S, Tanaka M, Juon HS (2012) Ethnic differences in prevalence and barriers of HBV screening and vaccination among Asian Americans. J Community Health 37(5):1071–1080. https://doi.org/10.1007/s10900-012-9541-4
Funding
This work has been funded by Zhejiang Medical Health Science and Technology Project (No. 2017203230).
Author information
Authors and Affiliations
Contributions
KW: literature review, investigation, data collection and analysis, and writing (original draft). HW: literature review, investigation, data collection and analysis, writing (review/edits), and funding acquisition. SL: literature review, investigation, data collection, and writing (review/edits). HZ: literature review, investigation, data collection, and writing (review/edits). BZ: conceptualization, investigation, data collection and analysis, funding acquisition, supervision, validation, and writing (review/edits).
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
This study was approved by the Medical Ethics Committee of Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China (Approval number: IRB-20200063-R).
Informed consent
Not applicable for this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wu, K., Wang, H., Li, S. et al. Maternal hepatitis B infection status and adverse pregnancy outcomes: a retrospective cohort analysis. Arch Gynecol Obstet 302, 595–602 (2020). https://doi.org/10.1007/s00404-020-05630-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-020-05630-2